Physician profile
Jane C Pan
NPI 1518113992
$1,892.50
in general payments reported to CMS, 2019-2025
24 companies · $469 in 2025
The $469 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $191 · 2021: $118 · 2022: $213 · 2023: $218 · 2024: $398 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,086.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,085.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $431.31 | 2019-2025 | Eylea, Eylea Hd |
| Genentech USA, INC. | $193.75 | 2022-2025 | Vabysmo |
| Alimera Sciences, INC. | $164.56 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $152.94 | 2019-2020 | |
| Oyster Point Pharma, INC. | $114.12 | 2022-2025 | Tyrvaya, Ryzumvi |
| Alcon Vision LLC | $107.02 | 2021-2025 | Clareon Panoptix Pro, Clareon, Tryptyr |
| Tarsus Pharmaceuticals, INC. | $93.44 | 2024-2025 | Xdemvy |
| Apellis Pharmaceuticals, INC. | $82.27 | 2022-2025 | Syfovre |
| Sun Pharmaceutical Industries INC. | $73.92 | 2022-2025 | Cequa |
| Abbvie INC. | $66.78 | 2023-2025 | |
| Allergan, INC. | $63.57 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $56.30 | 2022-2025 | Xipere, Visudyne |
| Ani Pharmaceuticals, INC. | $54.40 | 2025 | Iluvien, Purified Cortrophin Gel |
| New World Medical,INC. | $45.75 | 2024 | Ahmed Glaucoma Valve, Kahook Dual Blade, Clearpath |
| Johnson & Johnson Surgical Vision, INC. | $26.42 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $24.54 | 2024 | Cimerli |
| Spark Therapeutics, INC. | $24.15 | 2022 | |
| Rayner Intraocular Lenses Limited | $20.72 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Omeros Corporation | $17.53 | 2021 | |
| Harrow Eye, LLC | $16.61 | 2025 | Triesence |
| Ivantis, INC | $16.24 | 2020 | |
| Ocular Therapeutix, INC. | $14.73 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $12.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Pan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.